Occupational disease evaluation fee
Other
≈ ¥20-50
(≈ $3-7)
15 min
Disclaimer: This site is a medical service platform; some page content is AI-assisted. Health-related information does not constitute medical advice. If you have any questions, please consult a healthcare professional. See full disclaimer
Description
Estimated cost for Occupational disease evaluation fee at general public hospitals in China is about ¥15-40, and at Grade 3A hospitals about ¥20-50, varying by hospital tier and region.
Main Uses
Used exclusively to cover the cost of standardized clinical assessment for diagnosing occupational diseases (e.g., pneumoconiosis, occupational asthma, noise-induced hearing loss, chemical poisoning, occupational dermatitis); required for official certification under national occupational health laws; supports eligibility for workers’ compensation, disability benefits, and employer liability determination; applied after referral from occupational health institutions or employers following suspected work-related illness.
Normal Range
Not applicable — 'Occupational Disease Diagnosis Fee' is not a biomedical laboratory test with numerical values or reference ranges; it is an administrative/healthcare service charge for clinical evaluation, medical history review, occupational exposure assessment, and diagnostic confirmation of work-related illnesses per national occupational health regulations (e.g., China's 'Measures for the Diagnosis and Appraisal of Occupational Diseases'). No biological parameters or units are measured.
Low Values - Possible Causes
N/A — This is a fee, not a physiological measurement. A lower-than-expected fee may reflect regional pricing policies, subsidized public healthcare programs, diagnostic scope limitations (e.g., preliminary screening only), institutional waivers for vulnerable workers, or billing errors — not clinical pathology.
High Values - Possible Causes
N/A — As a service fee, elevated charges may result from comprehensive multi-specialty evaluation (e.g., pulmonology + neurology + toxicology), advanced testing add-ons (e.g., spirometry, audiometry, serum biomarkers, imaging), documentation complexity, legal/forensic appraisal requirements, private hospital pricing, or inclusion of follow-up management — not disease severity or lab abnormalities.